Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
May 14, 2024 17:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $277.0 Million in Q4 and $1,125.4 Million in Fiscal 2024Solid Consumption Trends in Q4 Offset by Near-Term Supply Chain ConstraintsAchieved Leverage Ratio of 2.8x at Year-End, Below...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
April 25, 2024 08:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on...
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
April 03, 2024 11:57 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine®. Seventy-five years later, Dramamine, a Prestige Consumer...
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
February 08, 2024 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior YearDiluted EPS of $1.06 in Q3, Up 2.2% Versus Prior YearReduced Leverage Ratio to 2.9x at Quarter EndRaising Full-Year Fiscal 2024 Earnings...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene
February 02, 2024 09:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
January 10, 2024 17:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 third quarter earnings release on Thursday,...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene
December 22, 2023 09:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine® 20% Benzocaine...
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene
November 24, 2023 08:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate...
Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
November 02, 2023 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $286.3 Million in Q2, Ahead of OutlookDiluted EPS of $1.07 in Q2, Up Over 5% Versus Prior YearReduced Leverage Ratio to 3.0x at Quarter EndReaffirming Full-Year Fiscal 2024 Revenue,...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
October 05, 2023 16:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 second quarter earnings release on Thursday,...